SCHEMBL16451639

SCHEMBL16451639

N[C@@H]1CCC1c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
HTR3A P46098 1/20 0.44
KDM1A O60341 7/20 0.43
MAOB P27338 3/20 0.43
MDM2 Q00987 1/20 0.43
KCNH2 Q12809 2/20 0.40
RCOR1 Q9UKL0 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
TAAR1 Q96RJ0 1/20 0.40
KDM1B Q8NB78 1/20 0.40
SLC9A1 P19634 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17806041 1.00 HTR2A (0.47) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL15282173 1.00 HTR2A (0.47) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL15291807 1.00 HTR2A (0.47) HTR2AHTR2CHTR2BHTR3AKDM1A
Hydrochloric Acid SCHEMBL16372230 0.98 HTR2A (0.50) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL2141184 0.87 HTR3A (0.46) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL2141187 0.87 HTR3A (0.46) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL1645815 0.87 HTR3A (0.46) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL4258361 0.87 HTR3A (0.46) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL4258364 0.87 HTR3A (0.46) HTR2AHTR2CHTR2BHTR3AKDM1A
SCHEMBL1644778 0.87 HTR3A (0.46) HTR2AHTR2CHTR2BHTR3AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 US disclosed
US-9414589-B2 N-cyclylamides as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2016-08-16 US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 US disclosed
US-20150045213-A1 N-CYCLYLAMIDES AS NEMATICIDES SYNGENTA CROP PROTECTION AG (CH) 2015-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS HTR2A 2168/4885HTR2C 602/4885HTR2B 735/4885
US-20150045213-A1 N-CYCLYLAMIDES AS NEMATICIDES TUBA3C, TUBA1C, TUBB3 HTR2A 3863/4885HTR2C 3245/4885HTR2B 3657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.